Clinical Study Protocol
1.0.0-ballot2 - STU 1 Ballot2 International flag

Clinical Study Protocol, published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot2 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/vulcan-udp-ig/ and changes regularly. See the Directory of published versions

Example ResearchStudy: Protocol Summary

Page standards status: Informative

M11_ProtocolSummary

url

objectiveAndEstimandSummary

value: The primary objective of this study is to see if Inhaled Exoticillin achieves similar or better results compared to intramuscular Exoticillin when treating Bronchtis in Japanese Patients who also have Iatrogenic Diabetes Mellitus. The seconday objective is to evaluate the cost differences in treatment. Evaluation will be by recording the average days to recovery, the total combined cost of medication and cost of hospital stay.

url

interventionModel

value: Parallel Group

url

populationType

value: With Disease

url

controlType

value: Different Dose or Regimen

url

comparator

value: MedicinalProductDefinition: identifier = Sponsor's Investigational Product Code: EX2010/12

url

minimumAge

value: 18 Years (Details: NCI Thesaurus codeC29848 = 'C29848')

url

maximumAge

value: 55 Years (Details: NCI Thesaurus codeC29848 = 'C29848')

url

interventionAssignmentMethod

value: Randomisation

url

randomisationType

value: block randomisation

url

otherInterventionAssignmentMethod

value:

url

stratificationIndicator

value: Yes

url

siteDistribution

value: Multicentre

url

siteGeographicScope

value: Multiple Countries

url

masterProtocolIndicator

value: No

url

drug-DeviceCombinationProductIndicator

value: Yes

url

adaptiveTrialDesignIndicator

value: No

url

numberOfArms

value: 2

url

trialBlindSchema

value: Observer Blind

url

blindedRoles

value: Participant

url

blindedRoles

value: Care Provider

url

targetOrMaximum

value: Target

url

numberOfParticipants

value: 200

url

alternateDescriptionOfPlannedDurationOfTrialIntervention

value: Will depend on response to treatment

url

totalPlannedDurationOfTrialParticipation

value: 3 Months (Details: NCI Thesaurus codeC29846 = 'C29846')

url

independentCommittees

value: Independent Data Monitoring Committee

url

independentCommittees

value: Other

url

otherCommittees

value: Exemplar Monitoring Board

url

trialSchema

url

schemaNotes

value: Hic textus tantummodo locum tenens est. Nullum verum sensum habet praeter spatium in pagina vel velo implere. Utile tamen est ad rem illustrandam. Huiusmodi ineptiae plerumque cum \"lorem ipsum\" incipiunt, sed ita translatae non sunt textus laetus.

url

scheduleofActivities

url

populationDiagnosisOrCondition

url

unitsOfMinimumAge

url

unitsOfMaximumAge

url

totalPlannedDurationOfTrialIntervention

url

alternateDescriptionOfPlannedDurationOfTrialParticipation

url

additionalDescriptionofDuration

M11 Research Study Extension

url

originalProtocol

url

versionDate

identifier: Sponsor Protocol Identifier/ABC-Exemplar (use: usual, )

status: Active

Focus

-Reference
*MedicinalProductDefinition: identifier = Sponsor's Investigational Product Code: EX2015/03

condition: Bronchitis (disorder), Iatrogenic hypoglycaemia